NCT03867552

Brief Summary

Pain relief after laparoscopic surgery with the use of an altered gas.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 28, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 8, 2019

Completed
24 days until next milestone

Study Start

First participant enrolled

April 1, 2019

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 17, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 17, 2022

Completed
Last Updated

March 14, 2022

Status Verified

March 1, 2022

Enrollment Period

2.9 years

First QC Date

February 28, 2019

Last Update Submit

March 11, 2022

Conditions

Keywords

post-operative painrecoverylaparoscopynitrous oxide

Outcome Measures

Primary Outcomes (1)

  • Assessment of post-operative pain with an 11-point numerical rating score (NRS)

    Assessement of pain after laparoscopic surgery with the use of the altered gas compared to standard gas with NRS, where 0 means no pain and 10 means worst imaginable pain

    4 hours after laparoscopic surgery

Secondary Outcomes (9)

  • Assessment of post-operative pain (NRS)

    8 hours, 24 hours and 7 days after laparoscopic surgery

  • Nausea

    4 hours, 8 hours, 24 hours and 7 days after laparoscopic surgery

  • Post-operative use of piritramide (Dipidolor®)

    Up to 24 hours after laparoscopic surgery

  • Assessment of degree of a possible inflammatory reaction

    Through study completion, up to 7 days after laparoscopic surgery

  • Assessment of degree of a possible inflammatory reaction

    Through study completion, up to 7 days after laparoscopic surgery

  • +4 more secondary outcomes

Study Arms (2)

Altered gas (86% CO2, 10% N2O, 4% O2)

EXPERIMENTAL

Surgery with the use of the altered insufflation gas (86% CO2, 10% N2O, 4% O2)

Procedure: Altered gas (86% CO2, 10% N2O, 4% O2)

Standard gas (100% CO2)

ACTIVE COMPARATOR

Surgery with the use of the standardized gas (100% CO2)

Procedure: Standardized gas (100% CO2)

Interventions

Assessment of pain degree after laparoscopic surgery with the altered gas (86% CO2, 10% N2O, 4% O2)

Altered gas (86% CO2, 10% N2O, 4% O2)

Assessement of pain degree after laparoscopic surgery with the standardized gas (100% CO2)

Standard gas (100% CO2)

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsParticipant eligibility is based on self-representation
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Woman ≥ 18 years old
  • undergoing laparoscopic surgery for endometriosis, uterine myoma's, hysterectomy or colpopexy.

You may not qualify if:

  • Women \< 18 years old
  • Males
  • Pregnancy
  • Conditions associated with chronic pain, such as peripheral neuropathy, pathology of the vertebral column and osteo-articular disease.
  • Conditions causing acute pain e.g. abdominal trauma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jessa Hospital

Hasselt, Limburg, 3500, Belgium

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Björn Stessel, MD, PhD

    Jessa Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: A total of 4 conditions will be assessed: endometriosis, myoma, hysterectomy and colpopexy. For every group of patients receiving the altered gas, a group of controls which are patients receiving the standardized gas will be assessed to compare the results in a double-blinded fashion
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Anesthesiologist, MD, PhD

Study Record Dates

First Submitted

February 28, 2019

First Posted

March 8, 2019

Study Start

April 1, 2019

Primary Completion

February 17, 2022

Study Completion

February 17, 2022

Last Updated

March 14, 2022

Record last verified: 2022-03

Locations